1181 related articles for article (PubMed ID: 11744011)
1. The inflammatory response in myocardial infarction.
Frangogiannis NG; Smith CW; Entman ML
Cardiovasc Res; 2002 Jan; 53(1):31-47. PubMed ID: 11744011
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mechanisms in myocardial infarction.
Ren G; Dewald O; Frangogiannis NG
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):242-56. PubMed ID: 14561159
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory response and cardiac repair after myocardial infarction.
Nah DY; Rhee MY
Korean Circ J; 2009 Oct; 39(10):393-8. PubMed ID: 19949583
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.
Zymek P; Nah DY; Bujak M; Ren G; Koerting A; Leucker T; Huebener P; Taffet G; Entman M; Frangogiannis NG
Cardiovasc Res; 2007 May; 74(2):313-22. PubMed ID: 17188669
[TBL] [Abstract][Full Text] [Related]
5. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
6. Targeting the inflammatory response in healing myocardial infarcts.
Frangogiannis NG
Curr Med Chem; 2006; 13(16):1877-93. PubMed ID: 16842199
[TBL] [Abstract][Full Text] [Related]
7. The role of the chemokines in myocardial ischemia and reperfusion.
Frangogiannis NG
Curr Vasc Pharmacol; 2004 Apr; 2(2):163-74. PubMed ID: 15320517
[TBL] [Abstract][Full Text] [Related]
8. Cellular recruitment in myocardial ischaemia/reperfusion injury.
Bonaventura A; Montecucco F; Dallegri F
Eur J Clin Invest; 2016 Jun; 46(6):590-601. PubMed ID: 27090739
[TBL] [Abstract][Full Text] [Related]
9. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury.
Frangogiannis NG; Mendoza LH; Lindsey ML; Ballantyne CM; Michael LH; Smith CW; Entman ML
J Immunol; 2000 Sep; 165(5):2798-808. PubMed ID: 10946312
[TBL] [Abstract][Full Text] [Related]
10. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
Vinten-Johansen J
Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
[TBL] [Abstract][Full Text] [Related]
11. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response.
Huebener P; Abou-Khamis T; Zymek P; Bujak M; Ying X; Chatila K; Haudek S; Thakker G; Frangogiannis NG
J Immunol; 2008 Feb; 180(4):2625-33. PubMed ID: 18250474
[TBL] [Abstract][Full Text] [Related]
12. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.
Frangogiannis NG; Lindsey ML; Michael LH; Youker KA; Bressler RB; Mendoza LH; Spengler RN; Smith CW; Entman ML
Circulation; 1998 Aug; 98(7):699-710. PubMed ID: 9715863
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Lakshminarayanan V; Lewallen M; Frangogiannis NG; Evans AJ; Wedin KE; Michael LH; Entman ML
Am J Pathol; 2001 Oct; 159(4):1301-11. PubMed ID: 11583958
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
[TBL] [Abstract][Full Text] [Related]
15. The immune system and cardiac repair.
Frangogiannis NG
Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
[TBL] [Abstract][Full Text] [Related]
16. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Dewald O; Zymek P; Winkelmann K; Koerting A; Ren G; Abou-Khamis T; Michael LH; Rollins BJ; Entman ML; Frangogiannis NG
Circ Res; 2005 Apr; 96(8):881-9. PubMed ID: 15774854
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
Frangogiannis NG
Inflamm Res; 2004 Nov; 53(11):585-95. PubMed ID: 15693606
[TBL] [Abstract][Full Text] [Related]
18. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
19. Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.
Baci D; Bosi A; Parisi L; Buono G; Mortara L; Ambrosio G; Bruno A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998408
[TBL] [Abstract][Full Text] [Related]
20. [Cardiac dysfunction and endogenous cytokines in global ischemia and reperfusion injury].
Kamikubo Y
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):813-26. PubMed ID: 8112707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
